Innovation to transform HPB outcomes​

Innovation to transform HPB outcomes​

Healthcare Professionals / GastroenterologyHPB Portfolio / Practical Solutions / Therapy / Chronic Pancreatitis 

Challenges of managing symptomatic pancreatic pseudocysts

Decorative Image

Approximately 5% to 16% of patients with acute pancreatitis and 20% to 40% of patients with chronic pancreatitis will develop pancreatic pseudocysts. While some patients are asymptomatic, others experience severe pain, bloating and poor digestion and must receive treatment.

​​Symptomatic pancreatic pseudocysts may be treated surgically, percutaneously, or endoscopically. However, surgery is associated with high rates of morbidity (7%-37%) and mortality (6%). Percutaneous drainage also provides limited treatment benefit as recurrence rates are high and fistulas may form.2

​​Purpose-built pseudocyst drainage tools can help healthcare professionals provide cost-effective therapies to improve patient health outcomes. Previously, endoscopic management of pancreatic pseudocysts has been difficult as the available technologies were not designed or intended for this purpose.​

Enabling efficient and effective treatment procedures

At Boston Scientific, we work tirelessly to deliver innovative solutions that help you offer the best possible treatment experience to your patients. 

Pancreatic Fluid Collection/Walled off necrosis drainage​

The Hot AXIOS™ System is intended to overcome the limitations of other drainage options.​

hot axios stent

Chronic Pancreatitis Case

Decorative Image
Explore the comprehensive treatment journey of a patient battling chronic pancreatitis, beginning from the pre-procedure phase and extending through his recovery. This in-depth case study has been developped in partnership with leading medical experts, providing you with valuable insights into our innovative HPB solutions.

Connect with us